Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as an Add-on to Metformin, Thiazolidinediones, or Both, in Patients With Type 2 Diabetes (SUSTAIN 2): A 56-Week, Double-Blind, Phase 3a, Randomised Trial
Specific ginsenosides, including Rb1 and Rg3, demonstrate significant efficacy in preclinical models of inflammatory disease, supporting their clinical potential for managing a broad range of inflammatory conditions (91)
between September 2022 and February 2024
Activated phagocytic cells produce hypochlorous acid, the product of myeloperoxidase (MPO) activity that is stimulated during immune activation, resulting in the 3-CT derivative
Your records are protected by HIPAA, consultations are conducted in private examination rooms, and the medication is dispensed discreetly
Careful Administration Tips for patients with conditions Certain groups, such as the elderly or individuals with other medical conditions, require personalized care